Catalent, Inc. (CTLT): Price and Financial Metrics

Catalent, Inc. (CTLT)

Today's Latest Price: $94.02 USD

0.62 (0.66%)

Updated Oct 23 7:00pm

Add CTLT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CTLT Stock Summary

  • CTLT has a market capitalization of $15,168,075,657 -- more than approximately 88.43% of US stocks.
  • CTLT's current price/earnings ratio is 87.68, which is higher than 90.6% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for CTLT is currently 34.45, higher than 88.76% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to Catalent Inc, a group of peers worth examining would be AME, STLD, WRK, BFAM, and LDOS.
  • Visit CTLT's SEC page to see the company's official filings. To visit the company's web site, go to

CTLT Stock Price Chart Interactive Chart >

Price chart for CTLT

CTLT Price/Volume Stats

Current price $94.02 52-week high $96.38
Prev. close $93.40 52-week low $31.04
Day low $92.21 Volume 544,630
Day high $94.11 Avg. volume 1,374,513
50-day MA $88.00 Dividend yield N/A
200-day MA $71.48 Market Cap 15.47B

Catalent, Inc. (CTLT) Company Bio

Catalent provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The company was founded in 2007 and is founded in Somerset, New Jersey.

CTLT Latest News Stream

Event/Time News Detail
Loading, please wait...

CTLT Latest Social Stream

Loading social stream, please wait...

View Full CTLT Social Stream

Latest CTLT News From Around the Web

Below are the latest news stories about Catalent Inc that investors may wish to consider to help them evaluate CTLT as an investment opportunity.

Clinical Trial Supplies Market Worth USD 2.5 Billion by 2025 - Leading Companies are Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK)

According to the new market research report "Clinical Trial Supplies Market by Products & Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology, Blood Disorders) - Global Forecast to 2025",

OpenPR | October 1, 2020

Starch Softgel Capsules Market Growth Trends and Competitive Strategies By Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc

A report by The Insight Partner's on the global Starch Softgel Capsules Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics

OpenPR | September 28, 2020

Tesla: Forget About Its Inclusion In The S&P 500

On September 8, the SP500 committee said "No" to Tesla (Nasdaq:TSLA) and published the 3 candidates to be included in the SP500: Etsy (Nasdaq:ETSY), Catalent (NYSE:CTLT) and Teradyne (Nasdaq:TER). There was much speculation about the possible incorporation of Tesla to the famous stock index, but, contrary to the forecasts that...

Francisco Javier Garcia on Seeking Alpha | September 25, 2020

Tesla shares slump 10% in premarket trading after S&P 500 snub

The S&P 500 Index Committee added Etsy, Teradyne and Catalent to the index Friday, but stopped short of including Tesla.

CNBC | September 8, 2020

Tesla stock tanks after capital raise, S&P 500 doesn’t add it

One thing that has been driving Tesla stock recently is the expectation that it would be added to the S&P 500. However, that didn’t happen, and investors started unloading the shares as a result. The S&P 500 Index Committee added Catalent, Etsy and Teradyne to the index on Friday, but it excluded Tesla stock. Q2 […] The post Tesla stock tanks after capital raise, S&P 500 doesn’t add it appeared first on ValueWalk .

ValueWalk | September 8, 2020

Read More 'CTLT' Stories Here

CTLT Price Returns

1-mo 14.69%
3-mo 16.53%
6-mo 36.48%
1-year 89.75%
3-year 118.55%
5-year 244.27%
YTD 67.00%
2019 80.56%
2018 -24.10%
2017 52.37%
2016 7.71%
2015 -10.22%

Continue Researching CTLT

Here are a few links from around the web to help you further your research on Catalent Inc's stock as an investment opportunity:

Catalent Inc (CTLT) Stock Price | Nasdaq
Catalent Inc (CTLT) Stock Quote, History and News - Yahoo Finance
Catalent Inc (CTLT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6884 seconds.